As most in the patent community know, last Friday, September 16, 2011, President Obama signed into law the long-awaited patent reform bill, known as the Leahy-Smith America Invents Act (“AIA”). There are many moving parts to this complicated piece of legislation—many consider it to implement the most sweeping changes to U.S. patent law since enactment … Continue reading this entry
Tags: Diagnostic Test, Gene Patent, Gene Patenting, Genetic Testing, H.R. 1249, Leahy-Smith America Invents Act, Patent Reform, Personalized Medicine, Section 27, Study on Genetic Testing
Yesterday, September 8, 2011, the Senate passed by a vote of 89-9 the House version of the patent reform bill H.R. 1249, also known as the Leahy-Smith America Invents Act, without amendment. Consequently, after many years of discussion, debate and hand-wringing, significant patent reform is imminent. In fact, at this point, the legislation only requires action … Continue reading this entry
Tags: Diagnostic Method Claims, Diagnostic Test, Gene Patent, Gene Patenting, Genetic Testing, H.R. 1249, Leahy-Smith America Invents Act, Patent Reform, Section 27, Study on Genetic Testing
